<DOC>
	<DOCNO>NCT01149993</DOCNO>
	<brief_summary>Patients undergo live donor renal transplant ask participate determine whether pre-operative dose immunosuppressive medication , donor organ receive additional dose antibody induction therapy help alleviate potential damage transplant organ post-transplant . A number lab test do post-transplant determine well kidney function .</brief_summary>
	<brief_title>Attenuating Ischemia Reperfusion Injury After Living Donor Renal Transplantation</brief_title>
	<detailed_description />
	<mesh_term>Wounds Injuries</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Reperfusion Injury</mesh_term>
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<mesh_term>Mycophenolic Acid</mesh_term>
	<mesh_term>Antilymphocyte Serum</mesh_term>
	<criteria>1 . Must able provide write informed consent . 2 . All recipient kidney live donor , either de novo transplant , retransplant 3 . All patient evaluate list United Network Organ Sharing ( UNOS ) eligible receive kidney transplant GUH 's standard protocol . 4 . Patients 1880 year age 1 . Recipients multiorgan transplant 2 . Patients known allergy hypersensitivity drug use protocol 3 . Recipients kidney decease donor 4 . Recipients coinfected Hepatitis B , Hepatitis C HIV 5 . Women pregnant 6 . Women childbearing potential , defined woman physiologically capable become pregnant , include woman whose career , lifestyle sexual orientation precludes intercourse male partner unless agree avoid pregnancy throughout duration trial 3 month follow trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>live donation</keyword>
	<keyword>kidney transplantation</keyword>
	<keyword>delay graft function</keyword>
	<keyword>ischemia reperfusion injury</keyword>
</DOC>